Pesole, P.L.; Liso, M.; Donghia, R.; Guerra, V.; Lippolis, A.; Mastronardi, M.; Iacovazzi, P.A.
90K/Mac-2 BP Is a New Predictive Biomarker of Response to Infliximab Therapy in IBD Patients. Int. J. Mol. Sci. 2023, 24, 3955.
https://doi.org/10.3390/ijms24043955
AMA Style
Pesole PL, Liso M, Donghia R, Guerra V, Lippolis A, Mastronardi M, Iacovazzi PA.
90K/Mac-2 BP Is a New Predictive Biomarker of Response to Infliximab Therapy in IBD Patients. International Journal of Molecular Sciences. 2023; 24(4):3955.
https://doi.org/10.3390/ijms24043955
Chicago/Turabian Style
Pesole, Pasqua Letizia, Marina Liso, Rossella Donghia, Vito Guerra, Antonio Lippolis, Mauro Mastronardi, and Palma Aurelia Iacovazzi.
2023. "90K/Mac-2 BP Is a New Predictive Biomarker of Response to Infliximab Therapy in IBD Patients" International Journal of Molecular Sciences 24, no. 4: 3955.
https://doi.org/10.3390/ijms24043955
APA Style
Pesole, P. L., Liso, M., Donghia, R., Guerra, V., Lippolis, A., Mastronardi, M., & Iacovazzi, P. A.
(2023). 90K/Mac-2 BP Is a New Predictive Biomarker of Response to Infliximab Therapy in IBD Patients. International Journal of Molecular Sciences, 24(4), 3955.
https://doi.org/10.3390/ijms24043955